DRUG · Unmapped registry intervention
Technosphere Insulin
Find medicine records ·
Find other trials using this name
Clinical trial
Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
NCT00332826
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedInhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Asthmaverified · MONDO: asthma
Interventions
Sponsors & collaborators
Mannkind Corporationlead sponsor
Mapped research locations
MoscowRussia5Porto AlegreBrazil3AtlantaGeorgia, United States2PhoenixArizona, United States2Long BeachCalifornia, United States2São PauloBrazil2New YorkNew York, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1TorontoOntario, Canada1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00332826 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.